Dasatinib

Overview

Dasatinib is a tyrosine kinase inhibitor being tested in multiple myeloma.

SparkCures ID 158
Developed By Bristol-Myers Squibb
Generic Name Dasatinib
Additional Names Sprycel, BMS-354825
Tags
  • Tyrosine Kinase (TK) Inhibitor

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.